bxp inc. - BXP

BXP

Close Chg Chg %
59.43 -0.45 -0.76%

Open Market

58.98

-0.45 (0.76%)

Volume: 880.49K

Last Updated:

May 11, 2026, 3:17 PM EDT

Company Overview: bxp inc. - BXP

BXP Key Data

Open

$59.58

Day Range

58.71 - 59.79

52 Week Range

49.72 - 79.33

Market Cap

$9.48B

Shares Outstanding

159.48M

Public Float

158.84M

Beta

1.06

Rev. Per Employee

N/A

P/E Ratio

29.83

EPS

$2.00

Yield

518.26%

Dividend

$0.70

EX-DIVIDEND DATE

Mar 31, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.89M

 

BXP Performance

1 Week
 
0.00%
 
1 Month
 
12.13%
 
3 Months
 
-3.35%
 
1 Year
 
-7.44%
 
5 Years
 
-45.07%
 

BXP Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 21
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 67.882
Number of Ratings 21 Current Quarters Estimate 0.459
FY Report Date 06 / 2026 Current Year's Estimate 1.806
Last Quarter’s Earnings 0.64 Median PE on CY Estimate N/A
Year Ago Earnings 1.74 Next Fiscal Year Estimate 1.895
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 5 5
Mean Estimate 0.46 0.52 1.81 1.89
High Estimates 0.64 0.69 2.63 2.63
Low Estimate 0.38 0.44 1.52 1.44
Coefficient of Variance 26.79 22.08 26.18 23.96

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 9 9
OVERWEIGHT 2 2 2
HOLD 10 11 12
UNDERWEIGHT 1 1 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Bxp Inc. - BXP

Date Name Shares Transaction Value
Apr 2, 2026 Bruce W. Duncan Director 13,274 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2026 Derek Anthony West Director 4,394 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2026 Joel Irwin Klein Director 23,515 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2026 Mary E. Kipp Director 7,951 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2026 Julie G. Richardson Director 1,367 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2026 Matthew J. Lustig Director 20,826 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2026 William H Walton Director 9,688 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2026 Hilary Spann Executive Vice President 23,327 Conversion of derivative security 0.00
Feb 27, 2026 Hilary Spann Executive Vice President of GP N/A Conversion of derivative security 0.00
Jan 28, 2026 Eric G. Kevorkian SVP, CLO and Secretary 511 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $67.11 per share 34,293.21
Jan 28, 2026 Michael E. LaBelle EVP and CFO 7,971 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $67.11 per share 534,933.81
Nov 26, 2025 Peter V. Otteni Executive Vice President N/A Open market or private sale of non-derivative or derivative security Non-derivative transaction at $72.65 per share 0.00
Nov 18, 2025 Peter V. Otteni Executive Vice President of GP N/A Conversion of derivative security 0.00
Nov 18, 2025 Peter V. Otteni Executive Vice President of GP 49,274 Conversion of derivative security 0.00
Aug 8, 2025 John J. Stroman Executive Vice President 16,838 Conversion of derivative security 0.00
Aug 8, 2025 John J. Stroman Executive Vice President of GP N/A Conversion of derivative security 0.00
Aug 8, 2025 John J. Stroman Executive Vice President of GP 51,351 Conversion of derivative security 0.00

Bxp Inc. in the News